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FAMILIAL CHILDHOOD-ONSET PROGRESSIVE
CEREBELLAR SYNDROME ASSOCIATED WITH
THE ATP1A3 MUTATION
The allelic disorders rapid-onset dystonia-parkinson-
ism (RDP), alternating hemiplegia of childhood
(AHC), and CAPOS/CAOS syndrome (cerebellar
ataxia, areflexia, pes cavus, optic atrophy, and senso-
rineural deafness) are caused by ATP1A3 muta-
tions.1–3 Intermediate RDP-AHC phenotypes are
emerging. Positional mutations 274, 583, 867, and
923 lead to both RDP and AHC, suggesting different
pathomechanisms.4,5 The E818K mutation underlies
all reported cases of CAPOS/CAOS, including an
AHC-CAPOS overlap syndrome.6 We report a family
with features of all 3 ATP1A3-spectrum disorders.
Case report. The proband (II-3; figure, A) is 49
years old, born at 32 weeks of gestation with pre-
eclampsia complicating pregnancy. Development
was delayed, walking at 28 months with progressive
gait ataxia, and speaking at 30 months. Hypertonia
and choreoathetosis were present at this time. Aged 5
years, she developed fever-induced acute-onset gen-
eralized hypotonia and dysarthria. Motor weakness
persisted for 8 months, requiring neurorehabilitation
to reacquire independent ambulation. Aged 6 years,
she developed limb incoordination and dysarthria,
worsening during febrile illnesses. Childhood-onset
painful limb spasms and stimulus-sensitive finger
myoclonus were reported. At 30 years, she noted
further worsening of dysarthria and ataxia. Exami-
nation at 49 years revealed short stature, low-set ears,
scoliosis, and pes planus. She had marked cerebellar
signs with dysarthria, dysmetria, square wave jerks,
intention tremor, and gait ataxia and spasticity with
preserved muscle strength, choreoathetosis, finger
myoclonus, and cervical dystonia. Reflexes were
absent and sensation intact. Fundoscopy and hearing
were normal. MRI showed cerebellar atrophy.
Individual III-2 was delivered at term and had de-
layed development, sitting at age 10 months, speak-
ing at 18 months, and walking at 27 months with
ataxia. At 30 months, she transiently lost the ability
to walk, with upper limb ataxia, lasting 3 weeks after
a febrile illness. She had another episode after Vari-
cella zoster infection, with acute-onset generalized
hypotonia, dysarthria, and dysphagia lasting for 1
month, followed by slow recovery. Examination at
age 5.5 years showed persistent cerebellar signs with
dysarthria, gait, and limb ataxia. She continues to
have episodic cerebellar deterioration during intercur-
rent illness, with a recovery period of 1–2 days and
complete return to baseline function. Examination at
20 years showed dysarthria, dysmetria, square wave
jerks, gait ataxia, spasticity with normal muscle
strength, global hyporeflexia with down-going plantar
responses, and normal sensation. Athetoid movement
of the hands, finger myoclonus, and scoliosis were
present. There was no visual or hearing impairment.
Brain MRI shows nonspecific mild periventricular
white-matter changes and normal cerebellar volume.
Individual IV-1 presented at age 8 months with
generalized weakness during a febrile illness, taking
3 weeks to recover and be able to sit independently
again. She started walking at age 17 months, and at
2 years, was ataxic and unable to walk independently.
Vision and hearing were normal.
Mutation analysis for spinocerebellar ataxias 1, 2,
3, 5, 7, and 17, dentatorubral-pallidoluysian atrophy,
ferritin light chains, and common mitochondrial
DNA mutations in the proband were negative, as
were plasma acylcarnitine profile, lactate, ammonia,
and amino acids. Whole-exome sequencing revealed
a deleterious missense mutation, c.2267G.A;
p.Arg756His (R756H), in ATP1A3, confirmed by
Sanger sequencing and shown to segregate with the
disease (figure, B).
Discussion. Infantile-onset RDP with motor delay
and initial fluctuations evolving into persistent dysto-
nia and ataxia is reported with R756H mutations.7
With the exception of IV-1, our patients presented
with motor delay prior to paroxysmal motor symp-
toms, with a protracted recovery period, consistent
with this picture. The development of a progressive
cerebellar syndrome with superimposed fever-
induced fluctuation is a key clinical feature in all
three affected members of our family as is global
hyporeflexia, suggesting some features also of
CAPOS/CAOS syndrome, without visual or auditory
involvement. Development of gait ataxia preceding
episodic features broadens the phenotype away from
CAPOS/CAOS and infantile-onset RDP.
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CAPOS are associated with pes cavus: recently,
cases without are reported.3 Our proband has flat feet,
and she and her daughter have scoliosis, extending the
musculoskeletal phenotype of ATP1A3-spectrum
syndromes. The age at onset in this family fits with
CAPOS/CAOS and AHC, and the development of
pyramidal signs and an extrapyramidal disorder
observed is more in keeping with nonparoxysmal
AHC/RDP features. Overall, the phenotypic presen-
tation has features of all three ATP1A3-spectrum
disorders. The early-onset cerebellar ataxia prior to
paroxysmal symptoms and extended musculoskeletal
involvement is novel. Early MRI is unavailable: how-
ever, cerebellar atrophy in adulthood is observed in
Figure Pedigree and genetics
(A) Family pedigree: no clinical information is available on the parents of the proband; Sanger sequencing confirmed the presence of c.2267G.A;
p.Arg756His (indicated by *) in the ATP1A3 gene in all affected family members and was absent in unaffected family members, II-1 and III-3 (indicated
by [-]). (B) Validation of mutation by Sanger sequencing. Chromatograms showing segregation of the variant with disease: present in affected family
members II-3, III-2, and IV-1 and absent in II-1 and III-3. (C) Mutation map of the ATP1A3 gene. ATP1A3 mutation map showing all published mutations
associated with rapid-onset dystonia-parkinsonism (RDP) (top panel), CAPOS/CAOS (top panel; highlighted in green), and alternating hemiplegia of childhood
(AHC) (bottom panel). Mutations underlined indicate frequently reported variants associated with the disease; mutations in our patients are indicated in red;
amino acid positions 274, 583, 923, and 801 highlighted in blue are mutated in both RDP and AHC; * indicates intronic splice-site variant c.2542 11G.A.
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the proband, suggesting possible progression and
development of fixed deficits observed in other neu-
rologic channelopathies.
Reporting unique ATP1A3-spectrum phenotypes
facilitates genotype-phenotype correlation, although
some phenotypic aspects may escape detection, di-
rects functional studies and possible therapeutic tar-
gets. We propose that ATP1A3 mutation analysis is
considered in patients with delayed motor develop-
ment and childhood- or early-onset progressive cere-
bellar syndromes with superimposed acute motor
fluctuations.
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